Notes 1. As the creators of the Research Diagnostic Criteria (RDC) wrote, “a major purpose of the RDC is to enable investigators to select relatively homogeneous groups of subjects who meet specified diagnostic criteria” (Spitzer et al., 1978). 2. As Pierre Macherey (1998) puts it, “the norm ‘produces’ the elements on which it acts as it elabo- rates the procedures and means of this action.” 3. As one pharmaceutical company executive wrote, “Pharmacogenetics will enable individuals to be classified according to their likely response to a medicine” (Roses, 2000: 860). An industry analyst (Sadee, 1998) writes that pharmacogenomics heralds “the therapeutic management of individual patients.” 4. John Maragnore, senior vice president of strategic product development, Millennium (in BioIT World, n.d.). 5. See Waldby (2001) for a similar argument with respect to the technical efficacy of the “central dogma” in molecular biology. References Aronowitz, Robert (1999) Making Sense of Illness: Science, Society, and Disease (Cambridge: Cambridge University Press). Biehl, Joaõ (2004) “The Activist State: Global Pharmaceuticals, AIDS, and Citizenship in Brazil,” Social Text 22(3): 105–32. Bodewitz, Henk J.H.W., Henk Buurma, & Gerard H. de Vries (1987) “Regulatory Science and the Social Medicine of Trust in Medicine,” in Wiebe E. Bijker, Thomas P. Hughes, & Trevor J. Pinch (eds), The Social Construction of Technological Systems: New Directions in the Sociology and History of Technology (Cam- bridge, MA: MIT Press): 243–60. Borch-Jacobsen, Mikkel (2002) “Prozac Nation,” London Review of Books July 9: 18–19. Boston Consulting Group (1999) “The Pharmaceutical Industry into Its Second Century: From Serendip- ity to Strategy,” January: 51–56. Bowker, Geoffrey, & Susan Leigh Star (1999) Sorting Things Out: Classification and Its Consequences (Cam- bridge, MA: MIT Press). Boyle, James (1997) Shamans, Software and Spleens: Law and the Construction of the Information Society (Cambridge, MA: Harvard University Press). Collier, Stephen J. & Andrew Lakoff (2004) “On Regimes of Living,” in Aihwa Ong & Stephen J. Collier (eds), Global Assemblages: Technology, Politics and Ethics as Anthropological Problems (Malden, MA: Blackwell). Conrad, Peter (1985) “The Meaning of Medications: Another Look at Compliance,” Social Science and Medicine 20(11): 29–37. Corrigan, Oonagh P. (2002) “A Risky Business: The Detection of Adverse Drug Reactions in Clinical Trials and Post-Marketing Exercises,” Social Science and Medicine 55: 497–507. Dumit, Joseph (2002) “Drugs for Life,” Molecular Interventions 2: 124–27. Ehrenberg, Alain (1998) La Fatigue d’être Soi: Dépression et Société (Paris: Odile Jacob). 756 Andrew Lakoff Epstein, Steven (2003) “Inclusion, Diversity, and Biomedical Knowledge Making: The Multiple Politics of Representation,” in Nelly Oudshoorn & Trevor Pinch (eds), How Users Matter: The Co-Construction of Users and Technology (Cambridge, MA: MIT Press): 173–90. Ewald, François (1990) “Norms, Discipline and the Law,” Representations 30: 138–61. Fishman, Jennifer (2004) “Manufacturing Desire: The Commodification of Female Sexual Dysfunction,” Social Studies of Science 34(2): 187–218. Fraser, Mariam (2001) “The Nature of Prozac,” History of the Human Sciences 14(3): 56–84. Fullwiley, Duana (2007) “The Molecularization of Race: Institutionalizing Racial Difference in Pharma- cogenetics Practice,” Science as Culture 11(1): 1–29. Gomart, Emilie (2002) “Methadone: Six Effects in Search of a Substance,” Social Studies of Science 32(1): 93–135. Grob, Gerald N. (1991) From Asylum to Community: Mental Health Policy in Modern America (Princeton, NJ: Princeton University Press). Guess, Harry A., Arthur Kleinman, John W. Kusek, & Linda W. Engel (eds) (2002) The Science of the Placebo: Toward an Interdisciplinary Research Agenda (London: BMJ Books). Hacking, Ian (1987) “Making up People,” in Thomas Heller, Morton Sosna, & David E. Wellbury (eds), Reconstructing Individualism: Autonomy, Individuality, and the Self in Western Thought (Stanford, CA: Stan- ford University Press): 222–36. Harrington, A. (2002) “‘Seeing’ the Placebo Effect: Historical Legacies and Present Opportunities,” in H. A. Guess, A. Kleinman, J. Kusak, & L. Engel (eds), The Science of the Placebo: Toward an Interdiscipli- nary Research Agenda (London: BMJ Books). Healy, David (1996) The Antidepressant Era (Cambridge, MA: Harvard University Press). Healy, David (2006) “The New Medical Oikumene,” in Adriana Petryna, Andrew Lakoff, & Arthur Kleinman (eds), Global Pharmaceuticals: Ethics, Markets, Practices (Durham, NC: Duke University Press). Hedgecoe, Adam & Paul Martin (2003) “The Drugs Don’t Work: Expectations and the Shaping of Phar- macogenetics,” Social Studies of Science 33(3): 327–64. Hughes, Thomas P. (1987) “The Evolution of Large Technological Systems,” in Wiebe E. Bijker, Thomas P. Hughes, & Trevor J. Pinch (eds), The Social Construction of Technological Systems: New Directions in the Sociology and History of Technology (Cambridge, MA: MIT Press). Kirk, Stuart A. & Herb Kutchins (1992) The Selling of DSM: The Rhetoric of Science in Psychiatry (New York: Aldine de Gruyter). Kleinman, Arthur (1988) Rethinking Psychiatry: From Cultural Category to Personal Experience (New York: Free Press). Kline, Nathan S. (ed) (1959) Psychopharmacology Frontiers: Proceedings of the Psychopharmacology Sympo- sium (London: J. & A. Churchill). Lakoff, Andrew (2000) “Adaptive Will: The Evolution of Attention Deficit Disorder,” Journal of the History of the Behavioral Sciences 36(2): 149–69. Lakoff, Andrew (2006) Pharmaceutical Reason: Knowledge and Value in Global Psychiatry (Cambridge: Cam- bridge University Press). Lakoff, Andrew & Stephen J. Collier (2004) “Ethics and the Anthropology of Modern Reason,” Anthro- pological Theory 4(4): 419–34. The Right Patients for the Drug 757 Lasagna, Louis, Frederick Mosteller, John M. von Felsinger, & Henry K. Beecher (1954) “A Study of the Placebo Response,” American Journal of Medicine 16(6): 770–79. Lovell, Anne M. (2006) “Addiction Markets: The Case of High-Dose Buprenorphine in France,” in Adriana Petryna, Andrew Lakoff, & Arthur Kleinman (eds), Global Pharmaceuticals: Ethics, Markets, Prac- tices (Durham, NC: Duke University Press). MacKenzie, Donald & Judy Wajcman (1985) The Social Shaping of Technology (Philadelphia: Open Uni- versity Press). Marks, Harry M. (1997) The Progress of Experiment: Science and Therapeutic Reform in the United States, 1900–1990 (New York: Cambridge University Press). McNair, D. M., G. Gardos, D. S. Haskell, & S. Fisher (1979) “Placebo Response, Placebo Effect, and Two Attributes,” Psychopharmacology 63: 245–50. Montag, Warren (ed) (1998) In a Materialist Way: Selected Essays by Pierre Macherey (New York: Verso). Montgomery, S. A. (1999) “The Failure of Placebo-Controlled Studies,” European Neuropsychopharmacol- ogy 9: 271–76. Nguyen, Vinh-Kim (2005) “Antiretroviral Globalism, Biopolitics, and Therapeutic Citizenship,” in Global Assemblages: Technology, Politics and Ethics as Anthropological Problems (Malden, MA: Blackwell). Nichter, Mark & Nancy Vuckovic (1994) “Agenda for an Anthropology of Pharmaceutical Practice,” Social Science and Medicine 39(11): 1509–25. Norton, Ronald (2001) “Clinical Pharmacogenomics: Applications in Pharmaceutical R&D,” Drug Dis- covery Today 6(4) (February): 180–85. Palsson, Gisli & Paul Rabinow (1999) “Iceland: The Case of a National Human Genome Project,” Anthro- pology Today 15(5): 14–18. Petryna, Adriana (2006) “The Human Subjects Research Industry,” in Adriana Petryna, Andrew Lakoff, & Arthur Kleinman (eds), Global Pharmaceuticals: Ethics, Markets, Practices (Durham, NC: Duke Univer- sity Press). Pignarre, Philippe (2001) Comment la Depression est devenue une Epidemie? (Paris: La Découverte). Rose, Nikolas (2001) “The Politics of Life Itself,” Theory, Culture and Society 18(6): 1–30. Rosenberg, Charles (2002) “The Tyranny of Diagnosis: Specific Entities and Individual Experience,” Milbank Quarterly 80(2): 237–60. Roses, Allen D. (2000) “Pharmacogenomics and the Practice of Medicine,” Nature 405(15): 857–65. Sadee, Wolfgang (1998) “Genomics and Drugs: Finding the Optimal Drug for the Right Patient,” Phar- maceutical Research 15(7): 959–63. Schatzberg, Alan F. & Helena C. Kraemer (2000) “Use of Placebo Control Groups in Evaluating Efficacy of Treatment of Unipolar Major Depression,” Biological Psychiatry 47(8): 745–47. Schull, Natasha (2006) “Machines, Medication, Modulation: Circuits of Dependency and Self-Care in Las Vegas,” Culture, Medicine, and Psychiatry 30(2): 223–47. Spitzer, R. L., J. Endicott, & E. Robins (1978) “Research Diagnostic Criteria: Rationale and Reliability,” Archives of General Psychiatry 35(6): 773–82. Swain, Gladys (1994) Dialogue avec l’Insensé: Essais d’Histoire de la Psychiatrie (Paris: Gallimard). Timmermans, Stefan & Marc Berg (2003) The Gold Standard: The Challenge of Evidence-Based Medicine and Standardization in Health Care (Philadelphia: Temple University Press). 758 Andrew Lakoff Van der Geest, Sjaak, Susan Reynolds Whyte, & Anita Hardon (1996) “The Anthropology of Pharma- ceuticals: A Biographic Approach,” Annual Review of Anthropology 25: 153–78. Waldby, Catherine (2001) “Code Unknown: Histories of the Gene,” Social Studies of Science 31(5): 779–91. Wilson, Mitchell (1995) “DSM-III and American Psychiatry: A History,” American Journal of Psychiatry 150(3): 399–410. Young, Allan (1996) The Harmony of Illusions: Inventing Post-Traumatic Stress Disorder (Princeton, NJ: Princeton University Press). The Right Patients for the Drug 759 [...]... research agenda on science and technology in the development process THREE PERSPECTIVES Science and Technology Studies Over the decade since the last edition of this Handbook, the social sciences have been flooded with analysis of processes of change in the world system, often under the Knowledge and Development 789 rubric of globalization (Worthington, 1993) Globalization has many meanings, but the predominant... scientist’s-eye view of science for legal audiences, the Manual helped reinforce a particular understanding of science s relationship to the law It is a small illustration of the broader proposition that the image of science the law defers to is importantly a construct of the legal process itself The law serves in this respect as a site and an instrument of co-production 772 Sheila Jasanoff Co-production The framework... science and evidence done by other students of the law Much of that analysis focused, especially from the early 1990s onward, on the law’s capacity to distinguish reliable from unreliable science and on the impact of the Supreme Court’s trilogy of evidence rulings At stake in these writings is the very nature of the adjudicatory process, with associated struggles for authority between science and the. .. destabilize the absolute certainty of the prosecution’s story and exonerated the suspect; yet, the very contingency of the outcome underscores the Dutch courts’ continued reliance on the neutrality of expertise and deference to the NFI as the legitimate source of forensic knowledge Preoccupied with the concept of expertise, and more generally with the problem of demarcation, STS scholars have not on the whole... typing, and engineering practice In keeping with the theme of deference, the FJC recruited David Goodstein, physicist and vice-provost of the California Institute of Technology (Caltech), to write a chapter entitled “How Science Works.” Goodstein critically reviewed the theories of three classic philosophers of science Bacon, Popper, and Kuhn—before offering his own account of the sociology of scientific... years of service on that body Similarly, apart from the historian of science Daniel Kevles, no other STS scholar sat on the National Academy of Science Committee on Science, Technology and the Law in its first six years The membership of both bodies consisted of professional lawyers and scientists Even I, of course, had a law degree 9 Brown v Board of Education of Topeka, Kansas, 347 U.S 483 (1954) 10... disease (Coutinho, 1999) The STS contribution to development is the freedom to envision both problems and solutions in local ways, without the imposition of the categories used in the sciences or technologies of the North New Growth Theory Economics provides another strand of thinking about science and technology in the global South Unlike STS, where Southern stories are not set apart, economics has a... draws attention to the ungovernable dimensions of science and technology, and by extension to the law’s role in managing the unmanageable through discourses of justice and reason (Jasanoff, 1995, 1990; Wynne, 1982) But as STS scholarship has importantly shown, the assumption of linearity, almost of determinism, built into the risk paradigm—casting science and technology as proactive and law as reactive—needs... institutions as their objects of study, STS analysts of science and the law are uniquely positioned to explore and question the hidden normativities underpinning the demarcations that matter in contemporary society These, as the CLS movement and its intellectual descendants most cogently argued, are the divides that consistently separate the weak from the strong, the rich from the poor, the disabled from the competent,... competent, and the socially marginal from the powerful and privileged Relentlessly concerned with the law’s epistemic authority, STS students of science, technology, and the law have been on the whole less attentive to the law’s Making Order: Law and Science in Action 781 magisterial role in constructing and maintaining justice, legitimacy, and constitutional order and, of course, in holding at bay the disruptive . within science and technology; we need equally to follow law-work and law-workers as they pass into and through the workplaces of science and technology. Second, the divergent cultural attributes and. epistemology, and culture. The section on engagements traces the relationship of science and technology with the law as a historical phenomenon and an emerging field of academic inquiry. The theme of authority. al., 1994) science. Accounts of the development of science are incomplete without taking on board the shaping influence of legal imperatives and imaginations, and of necessity the work of legal